Related Articles
RAC2 acts as a prognostic biomarker and promotes the progression of clear cell renal cell carcinoma
Identification and validation of DLX4 as a prognostic and diagnostic biomarker for clear cell renal cell carcinoma
DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway
KMT5A promotes metastasis of clear cell renal cell carcinoma through reducing cadherin‑1 expression
TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma